Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
The Neurohospitalist|July 13, 2023
Chimeric Antigen Receptor-T Cell Mediated Bilateral Facial Nerve Palsy: A Case ReportNatalya Patrick, Nizar Bahlis, Steven PetersLeukemia & Lymphoma|June 30, 2009
pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantationDouglas A Stewart, Nizar Bahlis, Adnan MansoorLeukemia & Lymphoma|June 13, 2015
Co-existent B-cell and plasma cell neoplasms: a case series providing novel clinical insightKareem Jamani, Peter Duggan, Paola Neri, et al.Leukemia & Lymphoma|November 22, 2017
Immunoparesis and polyclonal immunoglobulin recovery after auto-SCT for patients with multiple myeloma treated at a single institutionVictor H Jimenez-Zepeda, Peter Duggan, Paola Neri, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 7, 2021
Treatment response measurements and survival outcomes in a cohort of newly diagnosed AL amyloidosisVictor H Jimenez-Zepeda, Holly Lee, Sylvia McCulloch, et al.Leukemia & Lymphoma|March 29, 2011
Expression and prognostic significance of Oct2 and Bob1 in multiple myeloma: implications for targeted therapeuticsInka Toman, Jonathan Loree, Alexander C Klimowicz, et al.Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 8, 2021
Cyclophosphamide, Bortezomib and Methylprednisolone (CyBorMe) for the Treatment of AL Amyloidosis: Initial Experience From a Single CenterVictor H Jimenez-Zepeda, Holly Lee, Nowell Fine, et al.Current Oncology (Toronto, Ont.)|September 27, 2024
Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of CalgaryEllen Lewis, Nowell Fine, Sylvia McCulloch, et al.Cancer Chemotherapy and Pharmacology|March 14, 2007
O6-benzylguanine and BCNU in multiple myeloma: a phase II trialEric D Batts, Christopher Maisel, Donna Kane, et al.Genomics, Proteomics & Bioinformatics|February 13, 2021
Profiling Chromatin Accessibility at Single-cell ResolutionSarthak Sinha, Ansuman T Satpathy, Weiqiang Zhou, et al.Pageof 6